Bruker (BRKR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
10 Apr, 2026Executive summary
Annual meeting scheduled for May 21, 2026, with virtual attendance available for shareholders.
Shareholders are invited to vote on key proposals, including director elections, executive compensation, and auditor ratification.
Voting matters and shareholder proposals
Election of three Class II directors for a three-year term expiring in 2029: John J. (Jack) Phillips, Hermann F. Requardt, Ph.D., and Laura A. Francis.
Advisory vote on 2025 compensation for named executive officers.
Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.
Proxies may vote on other business arising at the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director nominees and auditor ratification.
Latest events from Bruker
- Q2 2026 saw revenue and margin growth, offset by a $134.9M goodwill impairment charge.BRKR
Q2 20265 Aug 2026 - All proposals, including director elections and incentive plan, were approved by stockholders.BRKR
AGM 20259 Jul 2026 - FY25 revenue up 2.1% but margins fell; FY26 guidance targets EPS and margin expansion.BRKR
Q4 20258 Jul 2026 - Order momentum, global growth, and cost savings set the stage for margin expansion through 2027.BRKR
Jefferies Global Healthcare Conference 20264 Jun 2026 - Directors elected, executive pay approved, and auditors ratified for 2026.BRKR
AGM 202621 May 2026 - Q1 2026 revenue up 2.7%, EPS down, but FY guidance reaffirmed with strong bookings and cost savings.BRKR
Q1 20267 May 2026 - 2026 proxy covers director elections, say-on-pay, auditor ratification, and robust ESG and governance.BRKR
Proxy filing10 Apr 2026 - Q2 2024 revenue up 17.4% as acquisitions drive growth, but margins pressured by costs.BRKR
Q2 20242 Feb 2026 - Innovation and acquisitions fuel growth in proteomics, diagnostics, and spatial biology.BRKR
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026